Transthyretin and Alzheimer's disease: where in the brain?
about
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous systemThe Adhesion GPCR GPR125 is specifically expressed in the choroid plexus and is upregulated following brain injury.The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epitheliumLipocalin 2 modulates the cellular response to amyloid beta.Analysis of the effects of sex hormone background on the rat choroid plexus transcriptome by cDNA microarraysClearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.Transthyretin Induces Insulin-like Growth Factor I Nuclear Translocation Regulating Its Levels in the HippocampusLongitudinal effects of intravenous immunoglobulin on Alzheimer's cerebrospinal fluid proteome.The Effect of Acute and Chronic Social Stress on the Hippocampal Transcriptome in MiceBMP4 sufficiency to induce choroid plexus epithelial fate from embryonic stem cell-derived neuroepithelial progenitors.Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity.Transthyretin: the servant of many masters.Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders.Multiplicity of cerebrospinal fluid functions: New challenges in health and diseaseGene Regulatory Effects of Ginkgo biloba Extract and Its Flavonol and Terpenelactone Fractions in Mouse Brain.Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approachesBlood-brain-barriers in aging and in Alzheimer's disease.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors.Transthyretin binding to A-Beta peptide--impact on A-Beta fibrillogenesis and toxicity.A Novel Plasma Based Biomarker of Alzheimer's Disease.The path from the choroid plexus to the subventricular zone: go with the flow!Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline.Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation.Transcriptome signature of the adult mouse choroid plexus.Lipocalin 2 is a choroid plexus acute-phase protein.Neuron-derived transthyretin modulates astrocytic glycolysis in hormone-independent manner.Transthyretin regulates hippocampal 14-3-3ζ protein levels.Progesterone enhances transthyretin expression in the rat choroid plexus in vitro and in vivo via progesterone receptor.Peripheral and central administration of T3 improved the histological changes, memory and the dentate gyrus electrophysiological activity in an animal model of Alzheimer's disease.Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus.Delivery of an anti-transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons.Copper mediated amyloid-β binding to Transthyretin
P2860
Q21202832-64C9748C-5903-48FF-85E4-C4DCFCA78B10Q26800095-93A2118F-0839-4FEB-BF89-6FA49F89A153Q33373826-E78B5ABD-79B2-43D6-8741-510AD2AA8427Q33639507-F6761133-C1F6-48B4-B743-13D0B97B75A7Q33706600-62655AB3-4183-42AE-A06F-27BCEAB116C6Q33898614-04C65919-8D66-45CF-830C-EA13597B02A5Q34153515-3E747C61-0692-4210-9502-AA916A1D7E67Q34667761-ADA86EF4-E941-4111-9DF0-7FC7BD53BA03Q34960461-36D6122F-69AD-4D3D-AB05-35EFAAA2DBB7Q35616785-1DDFDB80-3384-40C3-BD14-F8C190DEC57FQ35754467-5C045674-A5CE-4717-894D-C17E56ADC90DQ35837704-4D17EB8A-AA98-46F6-95E2-92D550D08AADQ36420755-8230B8D8-1947-403B-9206-18FC2E96DE91Q36497488-E106FB37-7B8E-4151-9B14-74DEE2816745Q36763960-819F0FEF-875F-4BC9-8A58-122A9E1C69C1Q36810822-FD54F4B7-6684-43D1-966E-4542057F3372Q37163564-066E534D-A8A6-4523-B247-02548E1D83DBQ37407500-393E0361-2E26-4968-8123-75718E47F698Q38007947-F1FF5B93-11C8-4883-A99F-A1C05DE2BADFQ38154683-01D20F64-B2D4-4A48-BA66-F0DED047B09EQ38256360-2182EE5B-076E-4E8A-82A9-219967E311C6Q38693438-4A0FBADD-22CE-4CFE-AFC0-B98EB656F0E4Q39389098-B2EF9536-B5A2-4639-AD68-E523DD1D8D53Q40009615-BA1338FC-FDFD-4069-A01F-D57BDEF120E9Q41325603-0003EAC4-EE08-4F7A-8344-B1BAF7D6A9F5Q41827406-DA37242B-BD8D-41D8-876B-06204F031CA8Q42026180-F35EFAC6-0F8C-4C05-B59F-4D6E6001E762Q42449948-1009FFC3-516F-4E36-9AA1-70C434BF9350Q42484451-2CDD6857-F07B-4867-A7C8-6FA1A6EA6150Q42519386-E695F796-39F2-4CD2-82A3-9F4A5B049A80Q47093838-BCB10183-989E-46C8-807D-F121F87B95A5Q48113132-C740B474-A814-4B40-A112-55581D45CB14Q48171447-92710F67-D8C4-4342-9501-40F29E562208Q48338967-2DCD80D2-EE97-40CC-BC1E-02FB8EAE102FQ48834842-F7189DE2-A857-40E5-9CD0-289D5D71B789Q52661451-FCB0D7FB-DD20-4099-B7B5-9130287E27F4Q58743863-B5CBC332-6BB2-4F44-80D2-B9A3D6CA317A
P2860
Transthyretin and Alzheimer's disease: where in the brain?
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transthyretin and Alzheimer's disease: where in the brain?
@ast
Transthyretin and Alzheimer's disease: where in the brain?
@en
type
label
Transthyretin and Alzheimer's disease: where in the brain?
@ast
Transthyretin and Alzheimer's disease: where in the brain?
@en
prefLabel
Transthyretin and Alzheimer's disease: where in the brain?
@ast
Transthyretin and Alzheimer's disease: where in the brain?
@en
P50
P1476
Transthyretin and Alzheimer's disease: where in the brain?
@en
P304
P356
10.1016/J.NEUROBIOLAGING.2006.03.015
P577
2006-05-15T00:00:00Z